Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany

The recently published S2k-guideline on (allergen-) specific immunotherapy (AIT) provides an excellent overview of the evidence on allergen preparations available for AIT in Germany based on the published efficacy studies. Publications based on the guideline are currently being used by the German as...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Allergo J Int
Main Authors: Brehler, Randolf, Klimek, Ludger, Vogelberg, Christian, Werfel, Thomas, Pfaar, Oliver, Hamelmann, Eckard
Format: Artigo
Jezik:Inglês
Izdano: Springer Medizin 2016
Teme:
Position Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4861740/
https://ncbi.nlm.nih.gov/pubmed/27226950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40629-016-0096-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki